CD8A and neoplasm: dMMR is associated with frameshift mutations that take place within the coding sequences, resulting in the production of functionally inactive proteins that can be presented via MHC molecules to CD8+ T cells as tumor neoantigens, consequently eliciting an antitumor immune response as well as the infiltration of T cells into the TME [177].